学科主题临床医学
Protein-Losing Enteropathy in Systemic Lupus Erythematosus: 12 Years Experience from a Chinese Academic Center
Chen, Zhen1,2,3; Li, Meng-Tao1,2,3; Xu, Dong1,2,3; Yang, Hong2,4; Li, Jing1,2,3; Zhao, Jiu-Liang1,2,3; Zhang, Heng-Hui5; Han, Shao-Mei2,6; Xu, Tao2,6; Zeng, Xiao-Feng1,2,3
刊名PLOS ONE
2014-12-09
DOI10.1371/journal.pone.0114684
9期:12
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Multidisciplinary Sciences
资助者Chinese National Key Technology RD Program ; Ministry of Science and Technology ; Chinese National High Technology Research and Development Program ; Research Special Fund for Public Welfare Industry of Health, Ministry of Health ; National Major Scientific and Technological Special Project for "Significant New Drugs Development&prime ; &prime ; Ministry of Science and Technology ; Chinese National Key Technology RD Program ; Ministry of Science and Technology ; Chinese National High Technology Research and Development Program ; Research Special Fund for Public Welfare Industry of Health, Ministry of Health ; National Major Scientific and Technological Special Project for "Significant New Drugs Development&prime ; &prime ; Ministry of Science and Technology
研究领域[WOS]Science & Technology - Other Topics
关键词[WOS]SERUM-ALBUMIN SCINTIGRAPHY ; CLASSIFICATION CRITERIA ; PATIENT ; GASTROENTEROPATHY ; PREDNISOLONE ; DIAGNOSIS ; DIARRHEA ; DISEASE ; EDEMA
英文摘要

Objective: Protein-losing enteropathy (PLE) is a complication in some systemic lupus erythematosus (SLE) patients that is often misdiagnosed. With this study, we provide insight into clinical characteristics, laboratory characteristics, diagnostic tests, risk factors, treatment, and prognosis of the disease.

Methods: A retrospective, case-control study was performed in 44 patients with SLE-related PLE (PLE group) and 88 patients with active SLE (control group) admitted to our care from January 2000-January 2012. Risk factors for SLE-related PLE were examined, and we analyzed the accuracy of single and combined laboratory characteristics in discriminating SLE-related PLE from active SLE. Serum albumin and C3 levels were measured as outcome during and after treatment with corticosteroids and immunosuppressive agents.

Results: The PLE group had lower mean serum albumin and 24-hour urine protein levels, higher mean total plasma cholesterol levels, and greater frequencies of anti-SSA and SSB seropositivity compared with the control group. Anti-SSA seropositivity, hypoalbuminemia, and hypercholesterolemia were independent risk factors for SLE-related PLE. The simultaneous presence of serum albumin (<22 g/l) and 24-hour urine protein (<0.8 g/24 h) had high specificity, positive predictive value, negative predictive value, and positive likelihood ratio, a low negative likelihood ratio and no significant reduction in sensitivity. High dosage of glucocorticosteroid combined with cyclophosphomide were mostly prescribed for SLE-related PLE.

Conclusion: SLE-related PLE should be considered when an SLE patient presents with generalized edema, anti-SSA antibody seropositivity, hypercholesterolemia, severe hypoalbuminemia, and low 24-hour urine protein levels. Aggressive treatment for lupus might improve prognosis.

语种英语
所属项目编号2008BAI59B02 ; 2012AA02A513 ; 201202004 ; 2012ZX09303006-002
资助者Chinese National Key Technology RD Program ; Ministry of Science and Technology ; Chinese National High Technology Research and Development Program ; Research Special Fund for Public Welfare Industry of Health, Ministry of Health ; National Major Scientific and Technological Special Project for "Significant New Drugs Development&prime ; &prime ; Ministry of Science and Technology ; Chinese National Key Technology RD Program ; Ministry of Science and Technology ; Chinese National High Technology Research and Development Program ; Research Special Fund for Public Welfare Industry of Health, Ministry of Health ; National Major Scientific and Technological Special Project for "Significant New Drugs Development&prime ; &prime ; Ministry of Science and Technology
WOS记录号WOS:000347515300065
引用统计
被引频次:3[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63504
专题北京大学第二临床医学院_北京大学肝病研究所
作者单位1.Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China
2.Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China
3.Peking Union Med Coll, Beijing 100021, Peoples R China
4.Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing 100730, Peoples R China
5.Peking Univ, Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China
6.Chinese Acad Med Sci, Dept Epidemiol & Stat, Beijing 100730, Peoples R China
推荐引用方式
GB/T 7714
Chen, Zhen,Li, Meng-Tao,Xu, Dong,et al. Protein-Losing Enteropathy in Systemic Lupus Erythematosus: 12 Years Experience from a Chinese Academic Center[J]. PLOS ONE,2014,9(12).
APA Chen, Zhen.,Li, Meng-Tao.,Xu, Dong.,Yang, Hong.,Li, Jing.,...&Zeng, Xiao-Feng.(2014).Protein-Losing Enteropathy in Systemic Lupus Erythematosus: 12 Years Experience from a Chinese Academic Center.PLOS ONE,9(12).
MLA Chen, Zhen,et al."Protein-Losing Enteropathy in Systemic Lupus Erythematosus: 12 Years Experience from a Chinese Academic Center".PLOS ONE 9.12(2014).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Chen, Zhen]的文章
[Li, Meng-Tao]的文章
[Xu, Dong]的文章
百度学术
百度学术中相似的文章
[Chen, Zhen]的文章
[Li, Meng-Tao]的文章
[Xu, Dong]的文章
必应学术
必应学术中相似的文章
[Chen, Zhen]的文章
[Li, Meng-Tao]的文章
[Xu, Dong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。